Table 4: Paired sample T-Test between 34 patients alive in MitraClip group and 27 alive in no-MitraClip group at 12-month follow up: Clinical and echocardiographic outcome.
| Baseline | 12-month | p value | |
| NYHA Class MitraClip Group | 2.8 ± 0.5 | 1.8 ± 0.8 | ≤ 0.001 |
| NYHA Class No-MitraClip group | 2.3 ± 0.7 | 2.1 ± 0.5 | 0.083 |
| LVEF (%) MitraClip Group | 30 ± 9 | 30 ± 9 | 0.533 |
| LVEF (%) No-MitraClip Group | 32 ± 7 | 33 ± 8 | 0.464 |
| EDV-LV (ml) MitraClip Group | 206 ± 67 | 201 ± 71 | 0.364 |
| EDV-LV (ml) No-MitraClip Group | 173 ± 58 | 170 ± 70 | 0.795 |
| ESV-LV (ml) MitraClip Group | 149 ± 59 | 140 ± 60 | 0.060 |
| ESV-LV (ml) No-MitraClip Group | 117 ± 48 | 119 ± 55 | 0.731 |
Variables are expressed as mean ± SD.
Abbreviations: Abbreviations as in Table 1.